New study reveals potential cognitive benefits of Shingrix vaccine. The shingles shot may offer protection against dementia, ...
Getting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...
While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...
Shingrix was hit hard in the first quarter as a result of the prioritisation of COVID-19 vaccination programmes in the US and other markets, with sales dropping almost 50% to £327 million, but ...
Shingrix grew 19% to £833 million in the quarter, backed up by solid performances for meningitis vaccines Bexsero and Menveo, which rose 34% to £218 million and 40% to £59 million, respectively.
India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand ...
The First in China! BLA Submitted for Luzhu Biotech's Recombinant Herpes Zoster Vaccine Expected to Be Launched in 2026 HONG KONG ...
More than 90,000 people in the Netherlands contract shingles each year, a painful viral infection that can lead to lifelong ...
Sales of Shingrix, its shingles vaccine, are also booming. GSK recorded $37.5 billion in revenue in 2023, up 3.4% from the previous year. Outside of GSK, Walmsley is also an independent director ...
LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun reviewing a prefilled syringe form of Shingrix, GSK's vaccine for shingles ...
Sales of Shingrix, its shingles vaccine, are also booming. GSK boosted Walmsley’s compensation 51% in 2023, owing to the company’s strong sales. GSK recorded £30.3 billion ($40.5 billion ...